Eur Respir J 2002; 20:1457-1463
Copyright ©ERS Journals Ltd 2002
Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients
A. Jung1,
I. Kleinau1,
G. Schönian2,
A. Bauernfeind3,
C. Chen1,
M. Griese4,
G. Döring5,
U. Göbel2,
U. Wahn1 and
K. Paul1
1 Children's University Hospital and 2 Institute of Microbiology and Hygiene, Medical Faculty Charité, Humboldt-University, Berlin, 3 Max-von-Pettenkofer-Institute for Microbiology and Hygiene and 4 Children's University Hospital, Ludwig-Maximilians-University, Munich and 5 Institute of Hygiene, Eberhard-Karls-University, Tübingen, Germany
CORRESPONDENCE: K. Paul, Universitätsklinikum Charité, Campus Virchow-Klinikum, Klinik für Pädiatrie mit Schwerpunkt Pneumologie/Immunologie, Augustenburger Platz 1, 13353, Berlin, Germany. Fax: 49 3045066983. E-mail: karl.paul@charite.de
Keywords: bronchoalveolar lavage, cystic fibrosis, Pseudomonas aeruginosa, pulsed-field gel electrophoresis, restriction fragment length polymorphism
Received: August 12, 2001
Accepted December 15, 2001
This study was supported by a grant from the foundation Mukoviszidose eV, Hoffmann-La Roche and by the Research Dept of the University Hospital Charité.
A controversy exists concerning the adequate specimen to characterise colonisation of cystic fibrosis (CF) airways by Pseudomonas aeruginosa. Oropharyngeal, sputum and bronchoalveolar lavage samples were evaluated from 38 stable CF patients for the detection of P. aeruginosa, genetically different isolates within the same host and longitudinal variations in the genotype during repeated examinations.
Bacterial isolates were typed by pulsed-field gel electrophoresis of deoxyribonucleic acid macrorestriction fragments.
Sensitivity, negative and positive predictive values and specificity to detect P. aeruginosa were 35.7, 73.5, 83.3 and 96.2% for oropharyngeal cultures in nonexpectorating patients and 91.7, 94.1, 100 and 100% for sputum cultures from expectorating patients, respectively. Genotypes of Pseudomonas isolates recovered from oropharyngeal swabs and sputum differed to the strains recovered by bronchoscopy in 55% and 40%, respectively. In 62% longitudinal variations in the genotype occurred. One-half of these alterations were detectable by bronchoscopy only.
In conclusion, sputum samples were of equal value as specimens from bronchoalveolar lavage to detect Pseudomonas aeruginosa colonisation. Cultures from the oropharynx are not suitable for characterising bacterial conditions in the cystic fibrosis lung. Different genotypes within the same host and longitudinal genetic alterations are common and may be detectable in the bronchoalveolar lavage fluid exclusively.
This article has been cited by other articles:

|
 |

|
 |
 
C Thauvin-Robinet, A Munck, F Huet, E Genin, G Bellis, E Gautier, M-P Audrezet, C Ferec, G Lalau, M D. Georges, et al.
The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening
J. Med. Genet.,
November 1, 2009;
46(11):
752 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Kremer, R. G. Zwerdling, P. H. Michelson, and B. P. O'Sullivan
Intensive Care Management of the Patient With Cystic Fibrosis
J Intensive Care Med,
May 1, 2008;
23(3):
159 - 177.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Davis, A. S. Brody, M. J. Emond, L. C. Brumback, and M. Rosenfeld
Endpoints for Clinical Trials in Young Children with Cystic Fibrosis
Proceedings of the ATS,
August 1, 2007;
4(4):
418 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Radhakrishnan, M. Corey, and S. D. Dell
Realities of Expectorated Sputum Collection in the Pediatric Cystic Fibrosis Clinic
Arch Pediatr Adolesc Med,
June 1, 2007;
161(6):
603 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Corech, A. Rao, A. Laxova, J. Moss, M. J. Rock, Z. Li, M. R. Kosorok, M. L. Splaingard, P. M. Farrell, and J. T. Barbieri
Early Immune Response to the Components of the Type III System of Pseudomonas aeruginosa in Children with Cystic Fibrosis
J. Clin. Microbiol.,
August 1, 2005;
43(8):
3956 - 3962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Griffiths, K. Jamsen, J. B. Carlin, K. Grimwood, R. Carzino, P. J. Robinson, J. Massie, and D. S. Armstrong
Effects of Segregation on an Epidemic Pseudomonas aeruginosa Strain in a Cystic Fibrosis Clinic
Am. J. Respir. Crit. Care Med.,
May 1, 2005;
171(9):
1020 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Beckmann, M. Brittnacher, R. Ernst, N. Mayer-Hamblett, S. I. Miller, and J. L. Burns
Use of Phage Display To Identify Potential Pseudomonas aeruginosa Gene Products Relevant to Early Cystic Fibrosis Airway Infections
Infect. Immun.,
January 1, 2005;
73(1):
444 - 452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Gibson, J. L. Burns, and B. W. Ramsey
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
October 15, 2003;
168(8):
918 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the European Respiratory Society.
|